|
ZNF180 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.23829860096703E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.88870047274281E-10 |
| Normal-vs-Stage2 |
1.57789999954971E-07 |
| Normal-vs-Stage3 |
3.82880000038277E-07 |
| Normal-vs-Stage4 |
9.23020548881937E-11 |
| Stage1-vs-Stage2 |
8.387400E-01 |
| Stage1-vs-Stage3 |
9.323600E-01 |
| Stage1-vs-Stage4 |
2.045600E-02 |
| Stage2-vs-Stage3 |
8.045200E-01 |
| Stage2-vs-Stage4 |
1.461840E-01 |
| Stage3-vs-Stage4 |
8.292100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.11609626990617E-11 |
| Normal-vs-AfricanAmerican |
6.22610000222679E-08 |
| Normal-vs-Asian |
3.044900E-03 |
| Caucasian-vs-AfricanAmerican |
3.130800E-01 |
| Caucasian-vs-Asian |
5.725000E-01 |
| AfricanAmerican-vs-Asian |
8.551800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62825308791525E-12 |
| Normal-vs-Female |
4.195100000004E-05 |
| Male-vs-Female |
2.984900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.05950000001332E-06 |
| Normal-vs-Extreme_Weight |
1.89914750592379E-12 |
| Normal-vs-Obese |
3.03329994455481E-09 |
| Normal-vs-Extreme_Obese |
3.39350000000405E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.723600E-02 |
| Normal_Weight-vs-Obese |
6.432200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.979000E-01 |
| Extreme_Weight-vs-Obese |
4.888400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.481200E-01 |
| Obese-vs-Extreme_Obese |
2.908600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13619999999137E-05 |
| Normal-vs-Age(41-60Yrs) |
3.04180000076926E-08 |
| Normal-vs-Age(61-80Yrs) |
2.53780330083941E-11 |
| Normal-vs-Age(81-100Yrs) |
4.60209999997296E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.999600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.460800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.860240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.166500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.654590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.838400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.81055170855871E-12 |
| Normal-VS-Type2 PRCC |
2.4272994725294E-10 |
| Normal-VS-KIRP CIMP |
2.35939999999601E-05 |
| Normal-VS-Unclassified PRCC |
1.22859999995839E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.299400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.447400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.816200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.351800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.406800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.270000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.55351295663786E-15 |
| Normal-vs-N1 |
8.13400000000408E-05 |
| Normal-vs-N2 |
2.38200000000077E-05 |
| N0-vs-N1 |
4.901700E-02 |
| N0-vs-N2 |
2.086400E-01 |
| N1-vs-N2 |
1.100170E-03 |
|
|
